12/11
08:08 am
itci
Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting [Yahoo! Finance]
Low
Report
Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting [Yahoo! Finance]
12/11
08:00 am
itci
Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting
Low
Report
Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting
12/4
01:28 pm
itci
ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD [Yahoo! Finance]
Low
Report
ITCI Submits sNDA to the FDA for Expanded Use of Caplyta in MDD [Yahoo! Finance]
12/3
07:42 am
itci
Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy [Yahoo! Finance]
Neutral
Report
Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy [Yahoo! Finance]
12/3
07:30 am
itci
Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy
Neutral
Report
Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy
11/29
01:00 pm
itci
Why Is Intra-Cellular (ITCI) Up 2.2% Since Last Earnings Report? [Yahoo! Finance]
Neutral
Report
Why Is Intra-Cellular (ITCI) Up 2.2% Since Last Earnings Report? [Yahoo! Finance]
11/27
11:16 am
itci
How Intra-Cellular surprised Wall Street by breaking character [Yahoo! Finance]
Low
Report
How Intra-Cellular surprised Wall Street by breaking character [Yahoo! Finance]
11/19
08:20 am
itci
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
11/19
08:00 am
itci
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Low
Report
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
11/7
08:00 am
itci
Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress
Low
Report
Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress
11/6
09:02 am
itci
Intra-Cellular bolsters Caplyta data with another Phase III win [Yahoo! Finance]
Low
Report
Intra-Cellular bolsters Caplyta data with another Phase III win [Yahoo! Finance]
11/5
07:00 am
itci
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
Low
Report
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
11/4
09:31 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at JPMorgan Chase & Co. from $81.00 to $89.00. They now have an "overweight" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at JPMorgan Chase & Co. from $81.00 to $89.00. They now have an "overweight" rating on the stock.
11/2
09:53 am
itci
Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results [Yahoo! Finance]
Low
Report
Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results [Yahoo! Finance]
11/1
08:53 am
itci
Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
10/30
09:25 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $100.00 price target on the stock.
High
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $100.00 price target on the stock.
10/30
07:30 am
itci
Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
High
Report
Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
10/17
08:00 am
itci
Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast
Low
Report
Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast
10/11
12:46 pm
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Morgan Stanley from $92.00 to $95.00. They now have an "overweight" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Morgan Stanley from $92.00 to $95.00. They now have an "overweight" rating on the stock.
10/4
11:36 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Royal Bank of Canada from $106.00 to $108.00. They now have an "outperform" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Royal Bank of Canada from $106.00 to $108.00. They now have an "outperform" rating on the stock.